Drug Hunter
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > AG-636
<< Back to October
dihydroorotate dehydrogenase inhibitor
in Ph. I for RR-lymphoma
from opt. of literature molecule
Mol. Cancer Ther., Oct. 20, 2020
Agios Pharmaceuticals, Cambridge, MA
AG-636 (Agios Pharmaceuticals dihydroorotate dehydrogenase (DHODH) inhibitor clinical candidate)
Unlock this content with a Premium membership to read it now.
